US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist

18.440
+3.150+20.60%

Close Jun 18 16:00 ET

1.13BMarket Cap-6932P/E (TTM)

Nurix Therapeutics Stock Forum

MARKET-TEST-DUMMY

23 hours ago

Same thoughts

$Nurix Therapeutics(NRIX.US)$
as this guy 👇

JESSE JAMES8832

Apr 12 03:58

watch for entry

$Nurix Therapeutics(NRIX.US)$

Trytosaveabit

Apr 11 15:11

Hehehe

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics Inc - Commenced an Underwritten Public Offering of $125 Mln of Its Common Stock

Meltyy

Mar 20 10:18

Biotech Stock News 3/20

$Annovis Bio(ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...

Moomoo AI

Mar 12 06:01

Investors may believe the company's poor revenue performance won't improve, causing a low P/S ratio. The company's future revenue growth is expected to be weaker than the industry average, causing discomfort among shareholders.

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Held Back By Insufficient Growth Even After Shares Climb 60%

Moomoo AI

Dec 20, 2023 07:24

Investors remain skeptical of Nurix Therapeutics' future despite strong performance, with its forecasted growth rate much lower than the industry's 235%. Current P/S ratio hints that expected growth may not justify a higher P/S, needing a turnaround to satisfy investor sentiment.

Improved Revenues Required Before Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock's 53% Jump Looks Justified

Trytosaveabit

Nov 1, 2023 15:44

News

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics (NASDAQ:NRIX) said that the FDA has placed a partial clinical hold on a Phase 1 study of its drug NX-2127 in the treatment of B-cell malignancies as the company’s shifts to a different manufacturing process for the product.
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...

Trytosaveabit

Oct 13, 2023 06:23

$Nurix Therapeutics(NRIX.US)$ Looking interesting here. just off ATL, recent good news. PT just set to 31! will be looking for place to take position for a swing. just thinking outloud

Trytosaveabit

Sep 7, 2023 06:12

NEWS!

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics Announces Collaboration With Seagen To Develop A Portfolio Of Degrader-Antibody Conjugates; Co. To Receive $60M Upfront Payment And Potential For $3.4B In Milestones Plus Royalties